NDC properties for "5000 MG Vogelxo 0.01 MG/MG Topical Gel" (RxCUI 1597134)
About this data
The tables show NDC propoerties for 5000 MG Vogelxo 0.01 MG/MG Topical Gel with the RxCUI 1597134
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 5000 MG Vogelxo 0.01 MG/MG Topical Gel (RxCUI 1597134)
| MMSL_CODE | BD22847 |
|---|---|
| NDA | NDA204399 |
| RxCUI | 1597134 |
| SPL_SET_ID | 2dd150f6-cdfd-4d51-8888-12b288f26262 |
| Prescribable Synonym | Vogelxo 1 % (50MG / 5GM) Transdermal Gel, 5 GM |
| RXNAV_STR | Vogelxo 50 MG Transdermal Gel, 5 GM |
| RxNorm Name | 5000 MG testosterone 0.01 MG/MG Topical Gel [Vogelxo] |
| RxNorm Synonym | 5000 MG Vogelxo 0.01 MG/MG Topical Gel |
| RxNorm Synonym | Vogelxo 50 MG Transdermal Gel, 5 GM |
| Related queries | Interactions (for RxCUI 1597134) |
NDC Properties
NDC Item 00245087105
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-05 |
| NDC Item | 00245087105 |
| Packaging | 30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-0871-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087135
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-35 |
| NDC Item | 00245087135 |
| Packaging | 30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (0245-0871-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087165
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-65 |
| NDC Item | 00245087165 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087189
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-89 |
| NDC Item | 00245087189 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087105
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-05 |
| NDC Item | 00245087105 |
| Packaging | 30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-0871-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087135
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-35 |
| NDC Item | 00245087135 |
| Packaging | 30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (0245-0871-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087165
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-65 |
| NDC Item | 00245087165 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087189
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-89 |
| NDC Item | 00245087189 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087105
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-05 |
| NDC Item | 00245087105 |
| Packaging | 30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-0871-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087135
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-35 |
| NDC Item | 00245087135 |
| Packaging | 30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (0245-0871-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087165
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-65 |
| NDC Item | 00245087165 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087189
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-89 |
| NDC Item | 00245087189 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087105
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-05 |
| NDC Item | 00245087105 |
| Packaging | 30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-0871-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087135
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-35 |
| NDC Item | 00245087135 |
| Packaging | 30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (0245-0871-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087165
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-65 |
| NDC Item | 00245087165 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |
NDC Item 00245087189
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-89 |
| NDC Item | 00245087189 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
| Related queries | Properties for NDC 9 0245-0871 |